Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system

Brain Research

Volumn 759, Issue 1, 1997, Pages 18-23

  Croiset, Gerda ^a   De Wied, David ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Pilocarpine; Seizure; Vasopressin; Vasopressin V2 receptor

Indexed keywords

ARGIPRESSIN; ARGIPRESTOCIN; OXYTOCIN; OXYTOCIN RECEPTOR; PILOCARPINE; RECEPTOR SUBTYPE; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; TONIC CLONIC SEIZURE;

ANIMALS; ARGININE VASOPRESSIN; BRAIN; DEAMINO ARGININE VASOPRESSIN; DRUG SYNERGISM; INJECTIONS, INTRAVENTRICULAR; MALE; MUSCARINIC AGONISTS; OXYTOCIN; PEPTIDE FRAGMENTS; PILOCARPINE; RATS; RATS, WISTAR; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; SEIZURES; VASOTOCIN;

EID: 0030798174     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00070-X     Document Type: Article

References (51)

1. Abe, H., Masumi, I., Tadashi M. and Ogata N., The effects of vasopressin on electrical activity in the guinea pig supraoptic nucleus in vitro, J. Physiol., 337 (1983) 665-685.
2. Antoni, F.A., Novel ligand specificity of pituitary vasopressin receptors in the rat, Neuroendocrinology, 39 (1984) 186-188.
3. Audigier, S. and Barberis, C., Pharmacological characterization of two specific binding sites for neurohypophyseal hormones in hippocampal synaptic plasma membranes of the rat, EMBO J., 4 (1985) 1407-1412.
4. Birnbaumer, M., Seibold, A., Gilbert, S., Ishido, M., Barberis, C., Antaramian, A., Brabet P. and Rosenthal, W., Molecular cloning of the receptor for human antidiuretic hormone, Nature, 357 (1992) 333-335.
5. Boakes, R.J., Ednie, J.M., Edwardson, J.A., Keith, A.B., Sahgal, A. and Wright, C., Abnormal behavioral changes associated with vasopressin-induced barrel rotations, Brain Res., 326 (1985) 65-70.
6. Boer, G.J., Development of vasopressin systems and their function, In D.M. Gash and G.J. Boer (Eds.), Vasopressin Principles and Properties, Plenum Press, New York, 1985, pp. 117-174.
7. 1-receptor and muscarinic cholinergic stimuli, Biochem. J., 221 (1984) 803-811.
8. Brinton, R.E. and MCEwen, B.S., Vasopressin neuromodulation in the hippocampus, J. Neurosci., 9 (1989) 752-759.
9. Brinton, R.E. and Brownson, E.A., Vasopressin-induction of cyclic AMP in cultured hippocampal neurons, Dev. Brain Res., 71 (1993) 101-105.
10. Burbach, J.P.H., Adan, R.A.H., Lolait, S.J., Van Leeuwen, F.W., Mezey, E., Palkovits, M. and Barberis, C., Molecular neurobiology and pharmacology of the vasopressin/oxytocin receptor family, Mol. Cell. Biol., 15 (1995) 573-595.
11. Caldwell, J.D., Mason, G.A., Stanley, F.A., Jerdack, G., Hryby, V.J., Hill, V.J., Prange Jr., A.J. and Pederson, C.A., Effects of nonapeptide antagonists on oxytocin and arginine-vasopressin induced analgesia in mice, Reg. Pept., 18 (1987) 233-241.
12. 2-like receptors, Brain Res. 479 (1989) 35-39.
13. Corcoran, M.E., Cain, D.P., Finlay, J.M. and Gillis, B.J., Vasopressin and the kindling of seizures, Life Sci., 35 (1984) 947-954.
14. 2 receptor subtype in the central nervous system, Eur. J. Pharmacol., 183 (1990) 506.
15. Croiset, G. and De Wied, D., Effects of ACTH on pilocarpine induced epilepsia: a structure-activity study, Eur. J. Pharmacol., 229 (1992) 211-216.
16. 3 pituitary vasopressin receptor, FEBS Lett., 356 (1994) 215-220.
17. De Wied, D., Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments, Life Sci., 19 (1976) 685-689.
18. De Wied, D., Gaffori, O., Burbach, J.P.H., Kovacs, G.L. and Van Ree, J.M., Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behavior of rats, J. Pharmacol. Exp. Ther., 241 (1987) 1-7.
19. De Wied, D., Elands, J. and Kovacs, G.L., Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?, Proc. Natl. Acad. Sci. USA, 88 (1991) 1494-1498.
20. De Wied, D, Diamant, M. and Fodor, M., Central nervous system effects of the neurohypophyseal hormones and related peptides, Front. Neuroendocrinol., 14 (1993) 251-302.
21. 8-vasopressin treatment: invovlement of neurohypophyseal peptide receptors, Pharmacol. Biochem. Behav., 47 (1994) 27-32.
22. 7]OT: a highly selective ligand for central and peripheral OT receptors, Am. J. Physiol, 254 (1988) E31.
23. Elands, J., Van Dorenmalen, E., Spruyt, B. and De Kloet, E.R., Oxytocin reptors in the rat hypothalamic ventromedial nucleus: a study of possible mediators of female sexual behavior, In S. Jard and R. Jamison (Eds.), Proceedings of the Third Vasopressin Conference, Montpellier (France) John Libbey, London, 1991, pp. 311-319.
24. Elands, J., De Kloet, E.R. and De Wied, D., Neurohypophyseal hormone receptors: relation to behavior, Progr. Brain Res., 91 (1992) 459-464.
25. Gillis, B.J. and Cain, D.P., Amygdala and pyriform cortex kindling in vasopressin deficient rats (Brattleboro strain), Brain Res. 271 (1983) 375-378.
26. 2 receptor mRNA in rats, Eur. J. Pharmacol., 267 (1994) 71-75.
27. Jard, S., Vasopressin isoreceptors in mammals: relation to cyclic AMP-dependent or cyclic AMP-independent transduction mechanisms, Curr. Top. Membr. Trans., 18 (1983) 255-285.
28. Kasting, N.W., Veale, W.L. and Cooper, K.E., Convulsive and hypothermic effects of vasopressin in the brain of the rat, Can. J. Physiol. Pharmacol., 58 (1980) 316-319.
29. Kasting, N.W., Veale, W.L., Cooper, K.E. and Lederis, K., Vasopressin may mediate febrile convulsions, Brain Res., 213 (1981) 327-333.
30. Kimura, R., Tanizawa, O., Mori, K., Brownstein, M.J. and Okayama, H., Structure and expression of a human oxytocin receptor, Nature, 356 (1992) 526-529.
31. Kirk, C.J. and Mitchell, R.H., Phosphatidylinositol metabolism in rat hepatocytes stimulated by vasopressin, Biochem. J., 194 (1981) 155-165.
32. Kovacs, G.L. and De Wied, D., Hormonally active arginine-vasopressin suppresses endotoxin induced fever in rats: lack of effect of oxytocin and a behaviorally active vasopressin fragment, Neuroendocrinology, 37 (1983) 258-261.
33. Kruse, J., Van Wimersma Greidanus, Tj.B. and De Wied, D., Barrel rotation induced by vasopressin and related peptides in rats, Pharmacol. Biochem. Behav., 7 (1977) 311-313.
34. Landgraf, R., Ramirez, A.D. and Ramirez, V.D., The positive feedback action of vasopressin on its own release from rat septal tissue in vitro is receptor-mediated, Brain Res., 545 (1991) 137-141.
35. 2 receptor and possible link to nephrogenic diabetes insipidus, Nature, 357 (1992) 336-339.
36. 1b vasopressin receptor gene, Proc. Natl. Acad. Sci. USA, 92 (1995) 6783-6787.
37. Lolait, S.J., O'Carroll, A. and Brownstein, M.J., Molecular biology of vasopressin receptors, Ann. NY Acad. Sci., 771 (1995) 273-292.
38. Manning, M. and Sawyer, W.H., Design and uses of selective agonistic and antagonistic analogs of the neuropeptides oxytocin and vasopressin, TINS, Jan. (1984) 6-9.
39. 1a arginine vasopressin receptor, Nature, 356 (1992) 523-526.
40. Naylor, A.M., Cooper, K.E. and Veale, W.L., Vasopressin and fever: evidence supporting the existence of an endogenous antipyretic system in the brain, Can. J. Physiol. Pharmacol., 65 (1986) 1333-1338.
41. 2 receptor messenger ribonucleic acid in the liver and kidney of embryonic, developing, and adult rats, Endocrinology, 133 (3) (1993) 1849-1859.
42. Racine, R.J., Modification of seizure activity by electrical stimulation: II Motor seizure, Electroencephalogr. Clin. Neurophysiol., 32 (1972) 281-294.
43. Sawyer, W.H, Grzonska, Z. and Manning, M., Neurohypophysial peptides, design of tissue specific agonists and antagonists, Mol. and Cell. Endocrinol., 22 (1981) 117-134.
44. 1b vasopressin receptor, J. Biol. Chem., 269, 27088-27092.
45. 1a vasopressin receptor, J. Biol. Chem., 269, (1994) 3304-3310.
46. Tribollet, E., Vasopressin and oxytocin receptors in the rat brain, In: T. Bjorklund, T. Hokfeldt and M.J. Kuhar (Eds.), Handbook of Chemical Neuroanatomy, Elsevier, Amsterdam, 1992, Vol. 4, pp. 289-320.
47. Turski, W.A., Cavalheiro, E.A., Schwarz, M., Czuczwar, S.J., Kleinrok, Z. and Turski, L., Limbic seizures produced by pilocarpine in rats: behavioral, electroencephalographic and neuropathological study, Behav. Brain Res. 9 (1983) 315-335.
48. Turski, L., Ikonomidou, C., Turski, W.A., Bortolotto, Z.A. and Cavalheiro, E.A., Review: cholinergic mechanisms and epileptogenesis, the seizures induced by pilocarpine: A novel experimental model of intractable epilepsy, Synapse 3 (1989) 154-171.
49. Urban. I. and De Wied, D., Effect of vasopressin, oxytocin and peptides derived from these hormones on field potential induced in lateral septum of rats by stimulation of the fimbria fornix, Neuropeptides 7 (1986) 41-49.
50. Wamil, A., Croiset, G., Kleinrok, Z. and De Wied, D., Beneficial effects of ACTH-(4-10) on pilocarpine induced seizures, Neurosci. Res. Commun., 4(2) (1989) 109-116.
51. Wurpel, J.N.D., Dundore, R.L., Barbella, Y.R., Balaban, C.D., Keil, L.C. and Severs, W.B., Barrel rotation evoked by intracerebroventricular vasopressin injections in conscious rats. I. Description and general pharmacology, Brain Res. 365 (1986) 21-29.